Globe Life (NYSE:GL) Issues Earnings Results

Globe Life (NYSE:GL) announced its quarterly earnings results on Wednesday. The company reported $4.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27, Zacks reports. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The company had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same quarter in the previous year, the firm posted $3.44 EPS. Globe Life updated its FY 2026 guidance to 14.600-15.300 EPS and its FY 2025 guidance to 14.400-14.600 EPS.

Globe Life Trading Down 0.4%

Shares of Globe Life stock opened at $135.52 on Thursday. The business has a fifty day simple moving average of $139.63 and a 200-day simple moving average of $129.18. The firm has a market cap of $10.98 billion, a price-to-earnings ratio of 10.83 and a beta of 0.55. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. Globe Life has a fifty-two week low of $100.27 and a fifty-two week high of $147.83.

Globe Life Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be issued a $0.27 dividend. The ex-dividend date is Friday, October 3rd. This represents a $1.08 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio is 8.63%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. JPMorgan Chase & Co. boosted their price target on Globe Life from $145.00 to $160.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Cfra Research upgraded Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. Truist Financial assumed coverage on Globe Life in a research report on Tuesday, July 15th. They set a “buy” rating and a $150.00 price target for the company. Wells Fargo & Company boosted their price target on Globe Life from $150.00 to $172.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Finally, Morgan Stanley set a $179.00 price objective on Globe Life and gave the company an “overweight” rating in a report on Tuesday, October 7th. Eight analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $152.11.

Insider Buying and Selling

In other news, CEO James Matthew Darden sold 33,270 shares of the business’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $135.59, for a total transaction of $4,511,079.30. Following the sale, the chief executive officer directly owned 49,842 shares of the company’s stock, valued at $6,758,076.78. The trade was a 40.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of the business’s stock in a transaction on Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total value of $4,081,363.44. Following the sale, the chief financial officer directly owned 30,665 shares in the company, valued at $4,322,845.05. This trade represents a 48.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 84,722 shares of company stock valued at $11,733,793 over the last ninety days. 1.51% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after buying an additional 607 shares during the period. NewEdge Advisors LLC raised its position in Globe Life by 368.1% during the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after buying an additional 5,352 shares during the period. Goldman Sachs Group Inc. raised its position in Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after buying an additional 58,163 shares during the period. Empowered Funds LLC acquired a new position in Globe Life during the first quarter valued at $428,000. Finally, Focus Partners Wealth raised its position in Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after buying an additional 656 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.